Oregon § 646A.685 Plan and methodology to establish upper payment limits for drugs sold in this state; report

Oregon Statutes

§ 646A.685 — Plan and methodology to establish upper payment limits for drugs sold in this state; report

Oregon § 646A.685

Vol.16

Title 50Trade Regulations and Practices

Ch. 646ATrade Regulation

This text of Oregon § 646A.685 (Plan and methodology to establish upper payment limits for drugs sold in this state; report) is published on Counsel Stack Legal Research, covering Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Or. Rev. Stat. § 646A.685 (2026).

Text

(1)The Prescription Drug Affordability Board established in ORS 646A.693 shall develop a plan for establishing upper payment limits on drugs sold in this state that are subject to affordability reviews under ORS 646A.694. The plan shall include:

(a)A methodology for establishing upper payment limits;

(b)An analysis of the resources needed by the board to implement the plan;

(c)An analysis of how upper payment limits would be enforced; and

(d)An analysis of how upper payment limits could be implemented with respect to:

(A)Plans administered by the Public Employees’ Benefit Board;

(B)Plans administered by the Oregon Educators Benefit Board;

(C)Other state-administered health benefits;

(D)Health benefit plans, as defined in ORS 743B.005; and

(E)Other forms of insurance that provide

Free access — add to your briefcase to read the full text and ask questions with AI

(1) The Prescription Drug Affordability Board established in ORS 646A.693 shall develop a plan for establishing upper payment limits on drugs sold in this state that are subject to affordability reviews under ORS 646A.694. The plan shall include:
(a) A methodology for establishing upper payment limits;
(b) An analysis of the resources needed by the board to implement the plan;
(c) An analysis of how upper payment limits would be enforced; and
(d) An analysis of how upper payment limits could be implemented with respect to:
(A) Plans administered by the Public Employees’ Benefit Board;
(B) Plans administered by the Oregon Educators Benefit Board;
(C) Other state-administered health benefits;
(D) Health benefit plans, as defined in ORS 743B.005; and
(E) Other forms of insurance that provide pharmaceutical benefits, to the extent permitted by federal law.
(2) No later than September 15, 2024, the Prescription Drug Affordability Board shall report to the interim committees of the Legislative Assembly related to health, in the manner provided in ORS 192.245, the following information:
(a) A detailed explanation of the plan developed under subsection (1) of this section.
(b) An analysis of potential savings from or costs of implementing the plan with respect to:
(A) The state;
(B) Insurers;
(C) Hospitals;
(D) Pharmacies; and
(E) Consumers.